References
- Bähr W., Theobald H. Organische Stereochemie, Begriffe und Definitionen. Springer, Berlin 1973; 11–12
- Baltzer V., Schmutz M. Experimental anticonvulsive properties of GP 47 680 and of GP 47 779, its main human metabolite; compounds related to carbamazepine. Advances in Epileptology, H. Meinardi, A.J. Rowan. Swets & Zeitlinger B.V., Amsterdam/Lisse 1978; 295–299
- Baumann P., Prelog V. Die stereospezifischc Reduktion von stereoisomeren Dekalindionen-(1,5). Helvetica Chimica Acta 1958; 41: 2379–2396
- Dieterle W., Faigle J.W. Preparative liquid-chromatographic methods in drug metabolism studies. Drug Metabolite Isolation and Determination, E. Reid, J.P. Leppard. Plenum Press, New York 1983; 13–22
- Dieterle W., Faigle J.W., Montigel C., Sulc M., Theobald W. Biotransformation and pharmacokinetics of acenocoumarol (Sintrom®) in man. European Journal of Clinical Pharmacology 1977; 11: 367–375
- Feldmann K.F., Brechbühler S., Faigle J.W., Imhof P. Pharmacokinetics and metabolism of GP 47 680, a compound related to carbamazepine, in animals and man. Advances in Epileptology, H. Meinardi, A.J. Rowan. Swets & Zeitlinger B.V., Amsterdam/Lisse 1978; 290–294
- Feldmann K.F., Dörhöfer G., Faigle J.W., Imhof P. Pharmacokinetics and metabolism of GP 47 779, the main human metabolite of oxcarbazepine (GP 47 680) in animals and human volunteers. Advances in Epileptology, M. Dam, L. Gram, J.K. Penry. Raven Press, New York 1981; 89–96
- Kalberer F., Rutschmann J. Eine Schnellmethode zur Bestimmung von Tritium, Radiokohlenstoff und Radioschwefel in beliebigem organischem Probenmaterial mittels des Flüssigkeits-Scintillations-Zählers. Helvetica Chimica Acta 1961; 44: 1956–1966
- Le Bigot J.F., Cresteil T., Kiechel J.R., Beaune P. Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation. Drug Metabolism and Disposition 1983; 11: 585–589
- McMahon R.E. Alcohols, aldehydes, and ketones. Metabolic Basis of Detoxication, W.B. Jakoby, R.J. Bend, J. Caldwell. Academic Press, New York 1982; 91–104
- Moreland T.A., Hewick D.S. Studies on a ketone reductase in human and rat liver and kidney soluble fraction using warfarin as a substrate. Biochemical Pharmacology 1975; 24: 1953–1957
- Nogradi M., Ollis W.D., Sutherland I.O. The conformational inversion of 2,3 : 6,7- dibenzo-derivatives of cycloheptatriene, tropone, heptafulvene, oxepin, thiepin, and azepin. Chemical Communications 1970; 158–160
- Perucca E. Pharmacokinetic interactions with antiepileptic drugs. Clinical Pharmacokinetics 1982; 7: 57–84
- Prelusky D.B., Coutts R.T., Pasutto F.M. Stereospecific metabolic reduction of ketones. Journal of Pharmaceutical Sciences 1982; 71: 1390–1393
- Rai P.V. Clinical trial for the estimation of anticonvulsive properties and side reactions of a new drug ketocarbamazepine. Advances in Epileptology, J.A. Wada, J.K. Penry. Raven Press, New York 1980; 357
- Reinikainen K., Keraenen T., Hallikainen E., Riekkinnen P.J. Substitution of diphenylhydantoin by oxcarbazepine or carbamazepine: double-blind study. Acta Neurologica Scandinavica 1984; 69(Suppl.)89–90
- Schütz H., Faigle J.W. Multiple inverse isotope dilution assay for cadralazine and four metabolites in biological fluids. Journal of Chromatography 1983; 281: 273–280
- Theisohn M., Heimann G. Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers. European Journal of Clinical Pharmacology 1982; 22: 545–551